Real world comparison of bruton tyrosine kinase inhibitors and venetoclax in patients diagnosed with chronic lymphocytic leukemia or small lymphocytic lymphoma Meeting Abstract

  


Authors: Roeker, L. E.; Han, Y.; Ryan, K. J.; Teschemaker, A.; Mato, A. R.
Abstract Title: Real world comparison of bruton tyrosine kinase inhibitors and venetoclax in patients diagnosed with chronic lymphocytic leukemia or small lymphocytic lymphoma
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 7025
End Page: 7027
Language: English
ACCESSION: WOS:000893230300012
DOI: 10.1182/blood-2022-163534
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato
  2. Lindsey Elizabeth Roeker
    132 Roeker
Related MSK Work